EUVIMEDEUVIMED entdecken
Crossref

Proteomics Platform Reveals Broad-Spectrum Nanobodies for SARS-CoV-2 Variant Neutralization

Ran Zhang, Lan Huang, Xiaohan Zhang, Yuanling Yu, Te Liang, Hongye Wang, Xiaomei Zhang, Di Hu, Bingwei Wang, Youchun Wang, Junyi Jiang, Xiaobo Yu iD

Journal of Proteome Research · 2024

DOI: 10.1021/acs.jproteome.3c00569 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Proteome Research, 2024. Verfasst von Ran Zhang und 11 weiteren Autor:innen. Beteiligte Einrichtung: School of Basic Medicine Sciences, Anhui Medical University, Hefei, Anhui 230031, PR China. Hauptthemen laut MEDLINE: SARS-CoV-2, Antibodies, Neutralizing, Single-Domain Antibodies, Proteomics. Die Arbeit nennt 39 Literaturangaben. Gefördert von: Guangdong Provincial Department of Science and Technology, National Key Research and Development Program of China, National Health Commission of the People's Republic of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SARS-CoV-2Antibodies, NeutralizingSingle-Domain AntibodiesProteomicsSpike Glycoprotein, CoronavirusCamelusCOVID-19Antibodies, ViralAnimalsHumansNeutralization Tests

Stichwörter der Autor:innen

SARS-CoV-2microarraynanobodyneutralizationproteomics

Substanzen

Antibodies, NeutralizingSingle-Domain AntibodiesSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2Antibodies, Viral

Autor:innen und Institutionen

  • School of Basic Medicine Sciences, Anhui Medical University, Hefei, Anhui 230031, PR China.
  • State Key Laboratory of Medical Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences-Beijing (PHOENIX Center), Beijing Institute of Lifeomics, Beijing 102206, China.
  • Changping Laboratory, Beijing 102206, China.
  • School of Medicine, Nanjing University of Chinese Medicine, Nanjing 210023, China.
  • ProteomicsEra Medical Co., Ltd., Beijing 102206, China.
  • Translational Medicine Technology Platform, National Center for Protein Sciences (Beijing), Beijing Institute of Lifeomics, Beijing 102206, China.

ORCID-Profile: Xiaobo Yu

Förderung

  • Guangdong Provincial Department of Science and Technology
  • National Key Research and Development Program of China
  • National Health Commission of the People's Republic of China
  • Beijing Municipal Natural Science Foundation
  • State Key Laboratory of Proteomics, Beijing Institute of Lifeomics

Zitieren

APA

Zhang, R., Huang, L., Zhang, X., Yu, Y., Liang, T., Wang, H., Zhang, X., Hu, D., Wang, B., Wang, Y., Jiang, J., & Yu, X. (2024). Proteomics Platform Reveals Broad-Spectrum Nanobodies for SARS-CoV-2 Variant Neutralization. Journal of Proteome Research. https://doi.org/10.1021/acs.jproteome.3c00569

Vancouver

Zhang R, Huang L, Zhang X, Yu Y, Liang T, Wang H, et al. Proteomics Platform Reveals Broad-Spectrum Nanobodies for SARS-CoV-2 Variant Neutralization. Journal of Proteome Research. 2024. doi:10.1021/acs.jproteome.3c00569

BibTeX
@article{Zhang2024,
  author = {Zhang, Ran and Huang, Lan and Zhang, Xiaohan and Yu, Yuanling and Liang, Te and Wang, Hongye and Zhang, Xiaomei and Hu, Di and Wang, Bingwei and Wang, Youchun and Jiang, Junyi and Yu, Xiaobo},
  title = {Proteomics Platform Reveals Broad-Spectrum Nanobodies for SARS-CoV-2 Variant Neutralization},
  journal = {Journal of Proteome Research},
  year = {2024},
  doi = {10.1021/acs.jproteome.3c00569}
}
Kostenlos starten →